Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of gadobenate dimeglumine-enhanced breast MRI and gadopentetate dimeglumine-enhanced breast MRI with mammography and ultrasound for the detection of breast cancer.
Gilbert FJ, van den Bosch HC, Petrillo A, Siegmann K, Heverhagen JT, Panizza P, Gehl HB, Pediconi F, Diekmann F, Peng WJ, Ma L, Sardanelli F, Belli P, Corcione S, Zechmann CM, Faivre-Pierret M, Martincich L. Gilbert FJ, et al. Among authors: corcione s. J Magn Reson Imaging. 2014 May;39(5):1272-86. doi: 10.1002/jmri.24434. J Magn Reson Imaging. 2014. PMID: 25006633 Clinical Trial.
Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L, Faivre-Pierret M, Zechmann CM, Corcione S, van den Bosch HC, Peng WJ, Petrillo A, Siegmann KC, Heverhagen JT, Panizza P, Gehl HB, Diekmann F, Pediconi F, Ma L, Gilbert FJ, Sardanelli F, Belli P, Salvatore M, Kreitner KF, Weiss CM, Zuiani C. Martincich L, et al. Among authors: corcione s. Radiology. 2011 Feb;258(2):396-408. doi: 10.1148/radiol.10100968. Epub 2010 Dec 16. Radiology. 2011. PMID: 21163915 Clinical Trial.
Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Sardanelli F, Podo F, Santoro F, Manoukian S, Bergonzi S, Trecate G, Vergnaghi D, Federico M, Cortesi L, Corcione S, Morassut S, Di Maggio C, Cilotti A, Martincich L, Calabrese M, Zuiani C, Preda L, Bonanni B, Carbonaro LA, Contegiacomo A, Panizza P, Di Cesare E, Savarese A, Crecco M, Turchetti D, Tonutti M, Belli P, Maschio AD; High Breast Cancer Risk Italian 1 (HIBCRIT-1) Study. Sardanelli F, et al. Among authors: corcione s. Invest Radiol. 2011 Feb;46(2):94-105. doi: 10.1097/RLI.0b013e3181f3fcdf. Invest Radiol. 2011. PMID: 21139507
Indications for breast magnetic resonance imaging. Consensus document "Attualità in senologia", Florence 2007.
Sardanelli F, Giuseppetti GM, Canavese G, Cataliotti L, Corcione S, Cossu E, Federico M, Marotti L, Martincich L, Panizza P, Podo F, Rosselli Del Turco M, Zuiani C, Alfano C, Bazzocchi M, Belli P, Bianchi S, Cilotti A, Calabrese M, Carbonaro L, Cortesi L, Di Maggio C, Del Maschio A, Esseridou A, Fausto A, Gennaro M, Girometti R, Ienzi R, Luini A, Manoukian S, Morassutt S, Morrone D, Nori J, Orlacchio A, Pane F, Panzarola P, Ponzone R, Simonetti G, Torricelli P, Valeri G. Sardanelli F, et al. Among authors: corcione s. Radiol Med. 2008 Dec;113(8):1085-95. doi: 10.1007/s11547-008-0340-z. Epub 2008 Oct 16. Radiol Med. 2008. PMID: 18953635 English, Italian.
MRI versus Mammography plus Ultrasound in Women at Intermediate Breast Cancer Risk: Study Design and Protocol of the MRIB Multicenter, Randomized, Controlled Trial.
Bonelli LA, Calabrese M, Belli P, Corcione S, Losio C, Montemezzi S, Pediconi F, Petrillo A, Zuiani C, Camera L, Carbonaro LA, Cozzi A, De Falco Alfano D, Gristina L, Panzeri M, Poirè I, Schiaffino S, Tosto S, Trecate G, Trimboli RM, Valdora F, Viganò S, Sardanelli F. Bonelli LA, et al. Among authors: corcione s. Diagnostics (Basel). 2021 Sep 8;11(9):1635. doi: 10.3390/diagnostics11091635. Diagnostics (Basel). 2021. PMID: 34573983 Free PMC article.
Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results.
Sardanelli F, Podo F, D'Agnolo G, Verdecchia A, Santaquilani M, Musumeci R, Trecate G, Manoukian S, Morassut S, de Giacomi C, Federico M, Cortesi L, Corcione S, Cirillo S, Marra V; High Breast Cancer Risk Italian Trial; Cilotti A, Di Maggio C, Fausto A, Preda L, Zuiani C, Contegiacomo A, Orlacchio A, Calabrese M, Bonomo L, Di Cesare E, Tonutti M, Panizza P, Del Maschio A. Sardanelli F, et al. Among authors: corcione s. Radiology. 2007 Mar;242(3):698-715. doi: 10.1148/radiol.2423051965. Epub 2007 Jan 23. Radiology. 2007. PMID: 17244718 Free article.
Screening women at intermediate risk: harm or charm?
Panizza P, Viganò S, Bonelli L, Bazzocchi M, Belli P, Calabrese M, Caramella D, Corcione S, Del Maschio A, Martincich L, Montemezzi S, Pediconi F, Petrillo A, Sardanelli F, Bruzzi P. Panizza P, et al. Among authors: corcione s. Eur J Radiol. 2012 Sep;81 Suppl 1:S116-7. doi: 10.1016/S0720-048X(12)70048-7. Eur J Radiol. 2012. PMID: 23083554 Clinical Trial. No abstract available.
Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study.
Podo F, Santoro F, Di Leo G, Manoukian S, de Giacomi C, Corcione S, Cortesi L, Carbonaro LA, Trimboli RM, Cilotti A, Preda L, Bonanni B, Pensabene M, Martincich L, Savarese A, Contegiacomo A, Sardanelli F. Podo F, et al. Among authors: corcione s. Clin Cancer Res. 2016 Feb 15;22(4):895-904. doi: 10.1158/1078-0432.CCR-15-0459. Epub 2015 Oct 26. Clin Cancer Res. 2016. PMID: 26503945
237 results